论文部分内容阅读
难治性青光眼是主要的致盲眼病之一,目前青光眼引流装置植入术已成为治疗难治性青光眼的主要方法,因其具有安全、有效、并发症较少等优点,青光眼引流装置在临床已得到广泛应用.通过近几年大量临床应用与青光眼微创手术的创新发展,青光眼引流装置植入术展现出良好的治疗前景.本文总结分析了青光眼外引流装置(Molteno、Schocket、Baerveldt、国产HAD房水引流物、Krupin、Ahmed、Joseph、Whites、Optimed房水引流物)及青光眼微创手术(Ex-PRESS青光眼引流器、Xen凝胶支架、CyPass微型支架、小梁消融术、Schlemm管支架、iStent引流器、SOLX Gold Shunt等)的结构特点和临床疗效,就青光眼引流装置植入术在治疗难治性青光眼中的作用进行综述.“,”Refractory glaucoma is one of the main blinding diseases in ophthalmology.Glaucoma drainage device implantation has become one of the main methods of refractory glaucoma.It has been widely used in clinic because of its advantages of safety,effectiveness and less complications.After a large number of clinical applications and innovative development of minimally invasive glaucoma surgery,glaucoma drainage device implantation shows its good treatment prospects.In this paper,the structural features of glaucoma external drainage device (Molteno,Schocket,Baerveldt,Human aqueous drainage,Krupin,Ahmed,Joseph,Whites,Optimed drainage device) and microin vasive glaucoma surgery (MIGS) (Ex-PRESS drainage device,Xen Gel Stent,CyPass Micro-Stent,Ab interno trabeculectomy trabectome,Hydrus Schlemm canal scaffold,iStent trabecular micro-bypass stent,SOLX Gold Shunt) were summarized.The drainage device implantations for glaucoma in the role of the refractory glaucoma were reviewed.